Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- The entries summarize the cited US FDA Trulicity label for type 2 diabetes.
- Initiate 0.75 mg SC once weekly; may increase to 1.5 mg for additional glycemic control.
- Higher doses (3.0 mg, 4.5 mg SC qwk) approved Sep 2020 for adults requiring additional glycemic control beyond 1.5 mg.
- Pediatric patients aged 10 years and older: 0.75 mg once weekly; if additional glycemic control is needed, the US label permits an increase to a maximum of 1.5 mg once weekly after at least 4 weeks. This is not weight-based.
- No dose adjustment needed for renal or hepatic impairment.